A Study on the Cultivation of Professional Values among Rural-Orientated Targeted Medical Students in Shaanxi Province

Objective:Through investigation,we can grasp the current situation of the professional identity of rural-orientated targeted medical students in Shaanxi Province,so as to cultivate these medical students to establish correct professional values,thus improving the performance rate.Methods:Questionnaires were distributed,and interviews were carried out in three colleges and universities in Shaanxi Province.Results:Targeted medical students lack professional understanding,and their professional identity needs to be improved through medical education.Conclusion:It is suggested that colleges and universities should take measures such as setting up courses and lectures,strengthening communication between teachers and students,carrying out ritual education and social practice,as well as selecting teaching teachers to strengthen the professional values of targeted medical students。

Improving Cost Savings and Patient Outcomes with Hepatitis C Triple Therapy Treatment in the Medicaid Population

One of the major infections that plague our world today, hepatitis C, has been causing liver disease in humans since early history. Over time, human ingenuity has allowed us to develop more effective treatments, but at traditionally massive monetary costs. In order to combat such costs, PerformRx came up with three ways to drive costs downward but also increase different outcomes for the Pennsylvania Medicaid population it serves. By restricting access to drugs via prior authorizations, tracking members within a DTM （drug therapy management） program, and giving members touchscreen tablet devices, there was an observed cost savings and a better ability to service members. Even though there was little impact on overall member outcomes, these initial interventions were the right steps to be innovative and create a beneficial scenario for both members and clients.

The impact of the provincial reimbursement scheme on the use of targeted anticancer medications in Zhejiang,China:a controlled interrupted time-series analysis

To alleviate problems with access and affordability,six targeted anticancer medications(TAMs)were listed in the Provincial Reimbursement Drug List(PRDL)for the first time in Zhejiang,China in February 2015.In the present study,we aimed to evaluate the implementation of the PRDL policy on TAMs use.Using the pharmaceutical procurement data of these six listed TAMs(study group)and four unlisted TAMs(control group)from 22 tertiary hospitals in Zhejiang,China dated between January 2014 and February 2017,interrupted time-series analysis was adopted to examine differences in the average hospital purchasing volume(HPV)and the average hospital purchasing spending(HPS)between the two groups.The average daily cost of listed TAMs in the study group was decreased after April 2015.After enlistment,the average HPV per month was significantly increased by 34.6 defined daily doses(DDDs)(P<0.001),and the average HPS per month was significantly increased by USD 6614.9(P<0.001)for the listed TAMs in the study group(n=6).Neither the average HPV nor the average HPS changed significantly for the unlisted TAMs in the control group(n=4).The PRDL policy showed positive effects on improving patients’affordability and promoting access to TAMs in Zhejiang.The government should conduct further price negotiations and include more TAMs with clinical benefits into reimbursement schemes to relieve patients’financial burden and promote access.